eGFR in Gout Treated with Pegloticase Does Not Differ Much With or Without Cotherapy with Methotrexate.

Kidney Week Video Pearls: Video Pearls from ASN's Kidney Week

First Once-Weekly Basal Insulin Approved for Type 2 Diabetes

Awiqli succeeds in type 2 after faltering in type 1 population

PCSK9 Drug Prevents First Heart Events in Diabetes Patients Without Atherosclerosis

VESALIUS-CV further extends PCSK9 inhibitor's primary prevention benefits

Complement Inhibitor Slowed Kidney Decline in IgA Nephropathy

Continued FDA approval of iptacopan was contingent on 2-year trial data

Large GLP-1 Drug Review Takes Closer Look at Risks, Rewards

Some potential non-cardiometabolic benefits lack strong evidence

Bipartisan Bill to Lower Insulin Costs Has Diabetes Advocates Hopeful

But similar bills haven't succeeded

Low-Income Patients Benefit From Intensive Blood Pressure Management

Trial included federally qualified health centers running SPRINT-like protocol

FDA Approves Sparsentan as First FSGS Treatment

Expanded indication supported by mixed bag of trial data

Low Hemoglobin Levels Linked to Higher Dementia Risk

Risk peaked when anemia occurred alongside abnormal Alzheimer's biomarkers

Primary Care Intervention Fails to Cut Heart Disease Risks

Multipronged education and feedback intervention for clinics did not have intended results

Rural Dialysis Unit Closes Despite State Getting $219M in Rural Health Funding

The influx of money is out of reach

Moderate Diet Change Tied to Renal Benefit in CKD

Findings suggest protein restriction doesn't have to be extreme

Differentiating the Trio of Focal Segmental Glomerulosclerosis Causes

Primary, secondary, and genetic cases require different treatment plans

Kids' Acute Kidney Injury Linked to These Lasting Health Risks

Meta-analysis details "long-term health issues that require ongoing monitoring"

Risk of Focal Segmental Glomerulosclerosis Recurrence After Kidney Transplant

Recurrence after kidney transplant linked to graft loss and mortality